Clinical Trial Results: PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the PARQuit smoking cessation intervention for adults with serious mental illness completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mental Illness
• Smoking Cessation
• Tobacco Use Disorder

Drugs mentioned

• PARQuit (PARQuit)

Snippet

Sponsor: University of California, San Francisco | Conditions: Smoking Cessation, Smoking, Tobacco | Phase 4 | Status: COMPLETED | Results posted: 2026-07-17